Usp18 deficiency is a very rare inherited condition that usually becomes clear before birth or in the newborn period. Early signs of Usp18 deficiency can include poor feeding, seizures, stiffness, breathing problems, and serious inflammation that affects the brain and other organs. Not everyone will have the same experience. Usp18 deficiency is lifelong, and it most often affects infants, with severe cases carrying a high risk of death early in life. Treatment focuses on supportive care, and some children may be considered for specialist medicines that reduce harmful interferon-driven inflammation.
How many people live with Usp18 deficiency?
Worldwide and U.S. estimates for USP18 deficiency are not consistently reported by a single trusted source. Orphanet describes it as an ultra-rare condition, but a firm count of how many people are living with it worldwide or in the United States is not available (Orphanet, 2024).
Overview
Usp18 deficiencySymptoms
Usp18 deficiency usually appears in newborns. Common features include severe inflammation, seizures, feeding or breathing problems, and a rash. Some babies also develop brain swelling or lasting developmental problems.
Outlook and prognosis
Usp18 deficiency can be life-threatening in newborns because severe inflammation may quickly affect the brain, liver, and lungs. With very early diagnosis and intensive treatment, some babies improve, but the outlook is still serious.
Causes and risk factors
Usp18 deficiency is caused by harmful changes in the USP18 gene, usually inherited when both parents pass on a nonworking copy. Parents who are related by blood may have a higher chance of having an affected child.
Genetic influences
Genetics are central to Usp18 deficiency because it is caused by harmful changes in the USP18 gene, usually inherited from both parents. Different genetic variants can affect how severe Usp18 deficiency is and when symptoms begin.
Diagnosis
Usp18 deficiency is diagnosed by recognizing the clinical features and checking immune system findings in blood tests. The genetic diagnosis of Usp18 deficiency is confirmed with genetic tests, and some children may also have imaging or other specialist tests.
Treatment and drugs
Treatment for Usp18 deficiency focuses on calming the overactive interferon response, often with Janus kinase inhibitors such as ruxolitinib, while closely managing feeding, breathing, seizures, and infections. Some babies also need intensive supportive care in the hospital.
Symptoms
Usp18 deficiency usually causes serious illness in the first days or weeks of life. Early on, this might look like a severe infection in a newborn, even when testing does not find one. The early features of Usp18 deficiency often involve the brain, skin, breathing, and feeding, and some babies become critically ill very quickly.
Many babies with Usp18 deficiency become very unwell soon after birth. They may need urgent hospital care because inflammation affects several parts of the body at once.
Poor sucking, vomiting, or trouble coordinating feeds can make it hard for a baby to take in enough milk. This often leads to slow weight gain and may require tube feeding.
Fast breathing, pauses in breathing, or low oxygen levels can happen early and can be severe. Some babies need oxygen or breathing support in the hospital.
Seizures can appear in the newborn period or early infancy and may be one of the first clear signs. Babies may also seem unusually stiff, jittery, or hard to soothe.
How people usually first notice Usp18 deficiency?
How Usp18 deficiency is first noticed is usually in the newborn period or early infancy, when a baby becomes very sick with signs of intense brain and body inflammation rather than a gradually developing problem over years. The first signs of Usp18 deficiency often include poor feeding, unusual sleepiness or irritability, seizures, trouble with muscle tone such as stiffness or floppiness, and sometimes breathing problems, with brain scans or other early tests showing inflammation or injury. In some families, doctors may first suspect it before birth because ultrasound shows concerning brain changes, but for many living with Usp18 deficiency, it is first recognized soon after delivery when a newborn has severe neurologic symptoms and needs urgent medical care.
Types of Usp18 deficiency
No distinct types of Usp18 deficiency are widely recognized.
Can I slow down the onset of symptoms?
No. USP18 deficiency is a very rare inherited condition, and symptoms usually begin before birth or very soon after birth, so there is no good evidence that diet, exercise, sleep, or other lifestyle changes can meaningfully delay its onset or prevent it from starting in an affected baby. Research is ongoing on medicines that may calm the body’s overactive immune response after symptoms appear, but these treatments are meant to manage the illness, not to stop it from beginning; if this condition runs in your family, genetic counseling and early testing can still help with planning and support.
What genetics can tell you about symptoms
In USP18 deficiency, genetics can tell a lot about symptoms because changes in the USP18 gene disrupt the body’s ability to turn down certain immune signals, which can lead to overwhelming inflammation. This condition usually starts very early, often before birth or in the newborn period, and many living with it develop severe problems such as brain inflammation, seizures, feeding difficulties, breathing problems, and major delays in development. Different genetic changes may affect how much USP18 function is left, so they can influence how severe the illness is and exactly when symptoms begin, although this disorder is generally considered a very serious, early-onset condition.
Causes and risk factors
USP18 deficiency is caused by harmful changes in both copies of the USP18 gene, usually inherited from each parent. These changes stop the body from switching off a strong immune signal called interferon, so inflammation can build up very early in life. The main risk is having two carrier parents, and this is more likely in families with a history of USP18 deficiency or when parents are biologically related. Genetic testing can sometimes clarify your personal risk. Lifestyle or everyday exposures do not cause USP18 deficiency, but infections and other stresses on the body may affect how severe symptoms become.
What are the most common causes or risk factors?
Usp18 deficiency is almost always caused by inheriting two changed copies of the USP18 gene, one from each parent, so it is a genetic condition that runs in families. The main risk factors are having both parents carry the same rare gene change, having a family history of the condition, and having parents who are related by blood, such as cousins, which makes sharing the same gene change more likely. There are no known lifestyle, diet, or environmental causes.
Environmental and biological risk factors
For Usp18 deficiency, there are no well-established environmental or non-genetic biological risk factors known at this time. Doctors often group risks into internal (biological) and external (environmental), but for this condition, research has not shown clear links with pregnancy exposures, maternal health issues, or birth events. In other words, the usual environmental and biological risk factors for Usp18 deficiency have not been clearly identified.
No environmental or non-genetic biological factor has been proven to increase the chance of Usp18 deficiency. Most reported cases do not point to a consistent outside trigger.
Maternal age, common health conditions during pregnancy, and routine pregnancy complications have not been confirmed as risk factors for Usp18 deficiency. If a pregnancy involved unusual illness or exposure, specialists may still review it case by case, but a clear causal link is not established.
Radiation, heavy metals, air pollution, and hormone-disrupting chemicals have not been shown to cause Usp18 deficiency. Research is limited because the condition is very rare, so careful medical review is still important when questions come up.
Common infections in pregnancy and standard medicines used during pregnancy have not been proven to increase the likelihood of Usp18 deficiency. No specific exposure in this group is recognized as an established cause.
Genetic risk factors
Usp18 deficiency usually happens when a child inherits two nonworking copies of the USP18 gene, one from each parent. In this condition, the gene change removes an important brake on the body’s interferon response, which can lead to severe inflammation very early in life. The main inherited risks are having carrier parents, a family history of the condition, or parents who are biologically related. When people ask about the genetic causes of Usp18 deficiency, the answer is usually this autosomal recessive pattern of inheritance.
USP18 changes: Usp18 deficiency is caused by harmful changes, also called variants, in the USP18 gene. These changes stop the gene from doing its usual job of calming part of the body’s immune signaling.
Two copies needed: Most people with Usp18 deficiency inherit two changed USP18 copies, one from each biological parent. This inheritance pattern is called autosomal recessive, and one changed copy alone usually does not cause the condition.
Carrier parents: Parents who each carry one changed USP18 copy usually have no symptoms themselves. When both parents are carriers, each pregnancy has a 1 in 4, or 25%, chance of Usp18 deficiency. There is also a 1 in 2, or 50%, chance that the child will be an unaffected carrier.
Family history: A family history of Usp18 deficiency or of a known USP18 gene variant raises the chance that other relatives may be carriers. This is especially important when there has already been an affected child in the family.
Related parents: When parents are biologically related, they are more likely to carry the same rare USP18 variant. That can increase the chance of Usp18 deficiency in their children.
Lifestyle risk factors
Because Usp18 deficiency is an inherited interferon-related disorder, lifestyle habits do not cause it. Still, how lifestyle affects Usp18 deficiency can be important for day-to-day symptom control, recovery, and the chance of complications, especially when the lungs, growth, skin, or nervous system are involved. The most useful lifestyle measures are the ones that reduce inflammatory strain, support nutrition and physical function, and help families carry out treatment plans safely.
Everyday hygiene habits, limiting avoidable exposure to sick contacts, and careful feeding and airway routines may lower the chance of infections that can trigger severe inflammation in Usp18 deficiency. Fewer infections can mean fewer hospitalizations and less stress on the lungs and overall immune system.
Poor intake, feeding difficulties, or inadequate calories can worsen growth failure and make recovery from illness harder in people with Usp18 deficiency. A nutrition plan that matches swallowing, feeding tube, or high-calorie needs can help support growth, strength, and immune resilience.
Gentle movement and prescribed physical or occupational therapy can help preserve mobility, joint range, and daily function when neurologic injury or weakness is present. Overexertion is not helpful, but tailored activity may reduce deconditioning and support breathing mechanics.
Irregular or poor-quality sleep can add physiologic stress and make irritability, fatigue, and caregiving challenges worse during a condition already marked by chronic inflammation. Consistent sleep routines may improve energy, recovery, and tolerance of therapies.
Risk prevention
Usp18 deficiency is a rare inherited immune condition, so there is no known way to prevent the condition itself if someone is born with it. Prevention usually means lowering the risk of serious infections, inflammation, and other complications through close medical care from infancy onward. Different people need different prevention strategies—there’s no single formula.
Regular follow-up with an immune specialist can help catch problems before they become severe. This is especially important if early symptoms of Usp18 deficiency, such as severe illness in a newborn or repeated infections, have already appeared.
Avoiding exposure to sick contacts, using careful hand hygiene, and getting quick assessment for fever can help lower the risk of dangerous infections in people with Usp18 deficiency. Families may also be advised on extra infection precautions during outbreaks or in crowded settings.
Vaccine choices may need to be tailored for people with Usp18 deficiency because some vaccines may not be appropriate depending on the person’s immune function and treatment plan. An immunology team can decide which vaccines are helpful and which should be delayed or avoided.
Prompt treatment of infections and inflammation can reduce the chance of organ damage and life-threatening complications. For many families, this means having a low threshold to seek urgent care when a baby or child seems unusually unwell.
Can you prevent Usp18 deficiency?
Usp18 deficiency usually cannot be prevented, because it is a very rare condition caused by an inherited gene change that is present from birth. If this condition runs in your family, genetic counseling and testing before or during pregnancy may help you understand the chances of having a child with it. These steps can help with family planning, but they do not guarantee prevention.
Transmission
Usp18 deficiency is a rare genetic condition, not an infection, so it cannot spread from one person to another through coughing, touch, kissing, sex, blood, or shared food. In most families, how Usp18 deficiency is inherited follows an autosomal recessive pattern, which means a child develops the condition only if they inherit two nonworking copies of the gene, one from each parent.
Parents who each carry one changed copy are usually healthy themselves, but with each pregnancy there is a 25% chance their child will have Usp18 deficiency, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither changed copy. Rarely, a new gene change may occur, but the genetic transmission of Usp18 deficiency is mainly through inherited gene changes rather than anything contagious.
When to test your genes
Consider genetic testing for USP18 deficiency as early as possible if a newborn or infant has unexplained severe inflammation, seizures, feeding problems, or brain findings that suggest an interferonopathy, a disorder caused by an overactive antiviral immune signal. Testing is also important if there is a known family history or an affected sibling, because an early diagnosis can guide treatment choices and future pregnancy planning.
Diagnosis
Usp18 deficiency is usually suspected when a baby becomes very unwell early in life, often with severe inflammation, infections, or signs of brain irritation. Because it is rare and can look like other serious newborn illnesses, the diagnosis of Usp18 deficiency often starts with a careful review of symptoms, exam findings, and routine hospital tests. Getting a diagnosis is often a turning point toward answers and support.
Doctors look at the overall pattern, especially symptoms beginning soon after birth such as fever, seizures, feeding problems, breathing trouble, or signs of severe inflammation. Brain-related symptoms and repeated serious illness can raise concern for an immune signaling problem rather than a routine infection.
Early lab tests often show inflammation, abnormal blood counts, liver test changes, or other signs that the immune system is overactive. These results do not prove Usp18 deficiency, but they help doctors recognize that something uncommon may be causing the illness.
Doctors usually begin by checking for bacterial, viral, and other infections because the first symptoms can closely mimic sepsis or meningitis. Tests may feel repetitive, but each one helps rule out different causes and supports the diagnosis of Usp18 deficiency when common explanations are not found.
Imaging findings on brain ultrasound or MRI may show inflammation or injury in the brain. A spinal fluid test may also be done if doctors need to look for infection or inflammation affecting the brain and spinal cord.
How is Usp18 deficiency diagnosed?
Usp18 deficiency is usually suspected in a baby with severe early inflammation, often starting before birth or soon after delivery, especially when there are brain scan changes, seizures, feeding problems, or other signs that can look like a serious infection but infection tests are negative. Doctors use the baby’s symptoms, exam findings, brain imaging, and blood tests that show an unusually overactive immune response to build the diagnosis. Genetic testing is then used to confirm it by finding harmful changes in the USP18 gene.
Stages of Usp18 deficiency
Usp18 deficiency does not have defined progression stages. This is because it is usually a genetic condition that shows up very early in life with a severe pattern of illness, rather than moving through clear step-by-step phases over time. Doctors usually start with a conversation about symptoms, pregnancy and birth history, and family background, then use blood tests, brain imaging, and genetic testing to confirm the diagnosis. In practice, monitoring focuses on the early symptoms of Usp18 deficiency, such as feeding problems, seizures, stiffness, or signs of brain inflammation, and on how well supportive treatment is working.
Outlook and prognosis
The outlook for USP18 deficiency is often poor without rapid recognition and intensive treatment, because affected infants can develop severe, early-onset inflammation with life-threatening neurologic and systemic complications. Reported cases show a high risk of death in the neonatal period or early infancy, especially when the disorder causes profound respiratory failure, seizures, liver dysfunction, or overwhelming inflammatory injury. Prognosis appears better when the condition is identified early and treated aggressively with supportive care and therapies that reduce type I interferon signaling, although experience remains limited because the disorder is extremely rare. Survivors may still have significant long-term neurodevelopmental impairment, feeding problems, or other chronic disabilities depending on how much damage occurred before treatment. Overall, mortality is substantial in the most severe presentations, but earlier diagnosis and targeted treatment may improve outcomes in some children.
Long-term effects
USP18 deficiency can affect long-term health in very different ways, depending on how severe the disease is early in life. In the most severe cases, inflammation can be overwhelming in infancy and may sharply shorten life expectancy. In children who survive, long-term effects often center on the brain, movement, growth, and hearing or vision. Long-term effects vary widely, and the outlook is often tied to how much early brain and body inflammation occurred.
USP18 deficiency can be life-threatening in the newborn period or early infancy. Some babies develop severe, widespread inflammation that leads to critical illness and a poor overall prognosis.
Many living with USP18 deficiency who survive infancy have lasting delays in motor, speech, and learning development. Early symptoms of USP18 deficiency often overlap with the brain inflammation that later shapes these long-term developmental differences.
Recurrent seizures can become an ongoing feature in some children with USP18 deficiency. Over time, seizure burden may add to learning and day-to-day functioning challenges.
Long-term brain injury may lead to stiffness, poor coordination, weakness, or involuntary movements. For many, this can mean delayed walking, difficulty with balance, or a lasting need for physical support.
How is it to live with Usp18 deficiency?
Living with USP18 deficiency is often very challenging because this rare genetic condition usually begins in the newborn period with severe inflammation, and many affected infants need intensive medical care, frequent hospital visits, and close follow-up from several specialists. For those who survive beyond early infancy, daily life can include feeding difficulties, seizures, movement problems, hearing or vision impairment, and developmental delays, although the exact pattern can vary from one child to another. For parents and other loved ones, the condition can reshape everyday life around caregiving, medical decisions, therapies, and constant monitoring, yet clear care plans and strong support from experienced medical teams can help families feel less alone.
Treatment and drugs
USP18 deficiency is usually treated by calming the body’s overactive interferon response and by supporting problems such as breathing trouble, feeding difficulty, seizures, or infections that can happen early in life. Because this condition is very rare and often severe in babies, treatment is usually led by a hospital team that may include genetics, neurology, and intensive care specialists. Doctors may use medicines that reduce inflammation, including steroids in some situations, and in some children they use targeted drugs called JAK inhibitors, which can help block the harmful immune signals driving USP18 deficiency. Not every treatment works the same way for every person, so care is adjusted to the child’s symptoms, age, and response, and families should ask the team about the best treatment for USP18 deficiency and what side effects to watch for.
Can you cure Usp18 deficiency?
No, there is no known cure for USP18 deficiency at this time. Because it is a rare inherited condition, treatment focuses on managing the overactive immune response, easing symptoms, and supporting problems such as serious illness in early life. In some cases, doctors may use medicines that calm this inflammation, but these treatments do not fix the underlying genetic cause.
Non-drug treatment
Living with Usp18 deficiency often means day-to-day care is focused on comfort, feeding, movement, communication, and development rather than one single therapy. Because this condition can affect the brain, muscles, hearing, vision, and growth, many living with Usp18 deficiency need care from several specialists at the same time. Supportive therapies can help children stay as comfortable and active as possible while families adapt care to changing needs. In practice, supportive care for Usp18 deficiency is tailored to each child’s symptoms and level of disability.
Physical therapy can help with stiffness, weakness, poor head control, and limited movement. Gentle stretching, guided positioning, and regular movement work may reduce discomfort and help prevent contractures over time.
Occupational therapy focuses on daily activities such as sitting, reaching, hand use, and safe positioning. It may also help with splints, seating systems, and other supports that make care and comfort easier.
Speech and language therapy may help with communication, even when spoken language is limited. For some children, it also supports feeding and swallowing skills, which can be affected in Usp18 deficiency.
Feeding therapy and nutrition support can help if eating takes a long time, causes coughing, or does not provide enough calories. Some children need texture changes, special feeding plans, or tube feeding to support growth and reduce aspiration risk.
Your genes may have an impact on how drugs work for you
In USP18 deficiency, the gene change itself is the main reason medicines can work differently, because it removes part of the body’s natural brake on immune signals and leaves inflammation turned up too high. This is why treatments that quiet those signals, including newer targeted medicines, may help some people more than standard anti-inflammatory drugs, while others may still have only partial improvement or may need very careful dose changes because side effects can be a concern. In day-to-day life, this can mean one child improves as swelling, fevers, or breathing problems settle, while another needs closer monitoring and a different treatment plan, so care is usually tailored to the individual rather than following a one-size-fits-all approach.
Pharmacological treatments
Treatment for Usp18 deficiency usually focuses on calming the overactive immune signaling that drives much of the illness, while also treating day-to-day problems such as seizures or muscle stiffness. Because this condition is very rare, there is no single standard drug plan, and care is often tailored to the symptoms and how severe they are. Not everyone responds to the same medication in the same way. In severe cases, treatment decisions are usually made by specialists in immunology, neurology, and genetics together.
Ruxolitinib and baricitinib are the main medicines doctors may use to reduce the excess interferon signaling seen in Usp18 deficiency. These drugs do not cure the condition, but they may help with inflammation and may improve some early symptoms of Usp18 deficiency in certain people.
Prednisone, prednisolone, or dexamethasone may be used to quickly lower inflammation when symptoms suddenly worsen. Their effect can be incomplete, and long-term use is limited by side effects such as poor growth, higher infection risk, and bone thinning.
If seizures are part of Usp18 deficiency, anti-seizure drugs such as levetiracetam, phenobarbital, or other standard epilepsy medicines may be prescribed. These treat the symptom itself rather than the underlying immune problem, so the choice depends on seizure type and age.
Baclofen or diazepam may be used when Usp18 deficiency causes marked stiffness, spasms, or discomfort that interferes with feeding, sleep, or care. Dosing may be increased or lowered gradually to balance benefit with sleepiness or weakness.
Genetic influences
For families living with USP18 deficiency, one of the hardest questions is why a baby became sick so early and whether it could happen again. It’s natural to ask whether family history plays a role. USP18 deficiency is a genetically defined condition caused by harmful changes in both copies of the USP18 gene, which normally helps put a brake on part of the body’s interferon response, an early immune alarm system. Because that brake is missing, the early symptoms of USP18 deficiency often begin in infancy, when immune signaling becomes too strong. It is usually inherited in an autosomal recessive pattern, meaning each parent often carries one changed copy without being ill, and a child is affected only if they inherit both changed copies. Since the genetic cause is known, testing can confirm USP18 deficiency, help estimate the chance of it happening again in a future pregnancy, and show whether close relatives may also be carriers.
Is Usp18 deficiency genetic?
Genetics are central to Usp18 deficiency because it is caused by harmful changes in the USP18 gene, usually inherited from both parents. Different genetic variants can affect how severe Usp18 deficiency is and when symptoms begin.
Having a genetic risk is not necessarily a diagnosis
Changes in genes are a normal part of human biology and are common throughout the general population. Most of these changes do not have a direct effect on health and are simply part of natural human variation. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
In Usp18 deficiency, the gene change is not just part of the diagnosis; it also helps explain why treatment needs to focus on an overactive immune signal rather than only on the symptoms it causes. Many living with Usp18 deficiency need medicines and hospital care to manage problems such as inflammation, infections, or neurologic complications, but those steps may not address the root cause by themselves. Genetic testing can sometimes identify how your body handles key immune signals, and in Usp18 deficiency it can point doctors toward medicines that reduce type I interferon activity, including drugs in the JAK inhibitor family. This is why how genetics affect treatment for Usp18 deficiency matters so much in day-to-day care. Some may improve with targeted treatment, while others still need intensive supportive care, because severity can vary even within the same condition. Since Usp18 deficiency is rare and often serious, treatment decisions are usually made by a team with experience in genetics, immune disorders, and the specific complications each person is facing.
Interactions with other conditions
For many living with Usp18 deficiency, other illnesses that trigger the immune system can make symptoms harder to manage, especially in infancy when the body is already dealing with high levels of inflammation. Infections are particularly important because they can worsen fever, breathing problems, feeding difficulties, or seizures, and they may look similar to the early symptoms of Usp18 deficiency itself. Certain diseases may overlap, meaning Usp18 deficiency can resemble congenital infections or other rare immune conditions that also cause brain inflammation, liver problems, or severe illness soon after birth. Because of that, doctors often need to carefully sort out whether a sudden decline is due to Usp18 deficiency, an infection happening at the same time, or both together. Interactions can look very different from person to person, but close follow-up is important since added illness can quickly place extra stress on the lungs, brain, and whole body.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Usp18 deficiency?
Usp18 deficiency can look a lot like severe infection in a newborn, especially infections picked up during pregnancy such as cytomegalovirus, because both can cause brain swelling or injury, seizures, poor feeding, rash, and liver problems. Doctors also think about Aicardi-Goutières syndrome and a few other rare conditions in which the body’s antiviral warning system stays switched on too strongly, since these can cause very similar inflammation and brain changes. Early on, serious illnesses like sepsis or meningitis may also be confused with it.
History
Doctors first recognized Usp18 deficiency through babies who became very sick soon after birth, often with signs of intense inflammation affecting the brain, blood, and other organs. In those early reports, the pattern looked a lot like a severe infection, even when no germ was found. For families, this could mean a newborn who seemed unwell from the start, with seizures, feeding problems, or breathing difficulties that were hard to explain.
In recent decades, awareness has grown as specialists began to connect these unusual cases and see that they were part of the same rare condition. At first, Usp18 deficiency was understood mainly by what doctors could observe: severe illness in early life, changes on brain scans, and laboratory signs of an overactive immune response. As medical science evolved, researchers recognized that this was not simply repeated infection or unexplained newborn illness, but a distinct disorder linked to problems in how the body controls interferon, a key immune signal.
That shift mattered because it changed how doctors think about the condition. Instead of viewing each case as an isolated mystery, they could place Usp18 deficiency within a broader group of inflammatory disorders now known as interferon-related conditions. Not every early description was complete, yet together they helped build the picture doctors use today.
The history of Usp18 deficiency is still fairly recent, and much of what is known has come from a small number of published cases. Because it is so rare, each newly described child has added important detail, including a better understanding of the early symptoms of Usp18 deficiency and how severe the condition can be in the newborn period. Looking back helps explain why diagnosis was often delayed in the past and why careful testing now plays such an important role when doctors suspect this disorder.